Genetic Technologies Ltd. Company Profile | StatInvestor

Health Care & Life Sciences » Biotechnology | Genetic Technologies Ltd.

Genetic Technologies Ltd.

Genetic Technologies Ltd.
Stock Exchange	Australian Stock Exchange
EPS	AUD0
Market Cap	AUD19.02 M
Shares Outstanding	2.72 B
Public Float	2.57 B

Genetic Technologies Ltd. ADR
Stock Exchange	NASDAQ Stock Market
EPS	$0.24
Market Cap	$11.78 M
Shares Outstanding	18.11 M
Public Float	-

Profile

Address	60-66 Hanover Street Fitzroy Victoria (VIC) 3065 Australia
Employees	-
Website	http://www.gtgcorporate.com
Updated	07/08/2019
Genetic Technologies Ltd. engages in the provision of molecular risk assessment for cancer. It operates through the USA and Australia geographical segments. Its product, BREVAGenplus, is a clinically validated risk assessment test for non-hereditary breast cancer.

Financials

Key People

Paul Alexander Kasian

Chairman & Chief Executive Officer

Jerzy Muchnicki

Executive Director